Ann M O'Mara
Affiliation: National Institutes of Health
- Health related quality of life in NCI-sponsored cancer treatment trialsAnn M O'Mara
Head, Palliative Care Research, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
Semin Oncol Nurs 26:68-78. 2010..To highlight health related quality of life (HRQOL) measures and published outcomes in phase III clinical trials in the four major cancers: breast, prostate, colorectal, and lung...
- Challenges to and lessons learned from conducting palliative care researchAnn M O'Mara
National Cancer Institute, Bethesda, Maryland 20892, USA
J Pain Symptom Manage 37:387-94. 2009..From a survey on the challenges and issues that emerged from their projects, grantees were able to identify specific hurdles and their unique solutions that may help other investigators as they plan their program of research...
- A needs assessment of oncology nurses' perceptions of National Cancer Institute-supported clinical trial networksAnn O'Mara
National Cancer Institute, Bethesda, MD, USA
Oncol Nurs Forum 34:E23-7. 2007..To describe oncology nurses' understandings of the function and infrastructure of, current level of participation in, and advantages and disadvantages to conducting research through cancer cooperative groups (CCGs)...
- Complementary and alternative medicine research and cooperative groups: can it happen?Ann O'Mara
National Cancer Institute, National Institutes of Health, 6130 Executive Blvd, EPN 2010, Bethesda, MD 20892, USA
J Pediatr Oncol Nurs 23:258-60. 2006..This report focuses on 2 CAM trials that opened and accrued participants in the Children's Oncology Group. One trial is aimed at preventing or reducing mucositis and the other at preventing chemotherapy-induced nausea and vomiting...
- Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experienceDavid R Buchanan
National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
J Clin Oncol 23:6682-9. 2005..To identify major research-design issues in proposals submitted by investigators in the Community Clinical Oncology Program (CCOP) for clinical trials of complementary and alternative medicine (CAM) for cancer-symptom management...
- Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsBryce B Reeve
Affiliations of authors Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC BBR, EB Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD SAM Division of Cancer Prevention, National Cancer Institute, Bethesda, MD LMM and AMO Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD AMD Division of Health Sciences Research, Mayo Clinic, Scottsdale, AZ ACD Feinberg School of Medicine, Northwestern University, Chicago, IL DC Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA CMR, DWB Department of General Oncology, MD Anderson Cancer Center, Houston, TX MJF Mayo Clinic Breast SPORE, Rochester, MN CCh Department of Psychological Research, The Netherlands Cancer Institute, Amsterdam, The Netherlands NKA Quality of Life Department, European Organization for the Research and Treatment of Cancer, Brussels, Belgium CCo
J Natl Cancer Inst 106:. 2014..We report the results of an evidence-synthesis and consensus-building effort that culminated in recommendations for core symptoms to be measured in adult cancer clinical trials that include a patient-reported outcome (PRO)...
- Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trialsDavid R Buchanan
Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
Cancer 110:1621-8. 2007..Finally, there is a growing appreciation that trials must be powered to test for effects on secondary endpoints...
- Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology ProgramLori M Minasian
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
Cancer 116:4440-9. 2010..By describing its keys to success, this article provides practical guidance to cancer-focused, provider-based research networks as well as those in other disciplines...
- Health-related quality of life and symptom management research sponsored by the National Cancer InstituteLori M Minasian
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7340, USA
J Clin Oncol 25:5128-32. 2007..The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations...
- Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology ProgramDavid R Buchanan
Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
J Clin Oncol 23:591-8. 2005..To examine how quality of life (QOL) is prospectively conceptualized, defined, and measured in the symptom management clinical trials supported by the National Cancer Institute Community Clinical Oncology Program (CCOP)...
- Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC EB, BBR, AVB Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC EB, BBR, AVB Department of Epidemiology and Biostatistics, Health Outcomes Research Group EB, LS, LR and Department of Psychiatry and Behavioral Sciences JH, TMA, Memorial Sloan Kettering Cancer Center, New York, NY Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences SAM, SBC, Division of Cancer Prevention LMM, NCTN Clinical Trials Operations, Cancer Therapy Evaluation Program AD, Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention AMO, DSG, JK, and Investigational Drug Branch, Cancer Therapy Evaluation Program AC, National Cancer Institute, Bethesda, MD Division of Health Sciences Research, College of Medicine, Mayo Clinic Arizona, Scottsdale, Unidad de Salud Respiratoria
J Natl Cancer Inst 106:. 2014..It is envisioned that the PRO-CTCAE will enhance the precision and patient-centeredness of adverse event reporting in cancer clinical research. ..
- Clinical trials referral resource. Current clinical trials in the treatment of colorectal cancerMargaret M Mooney
National Cancer Institute, Bethesda, MD, USA
Oncology (Williston Park) 20:830, 832, 837-8 passim. 2006
- Clinical trials referral resource. Current clinical trials of supportive care/palliative careMason Schoenfeldt
EMMES Corporation, Rockville, MD, USA
Oncology (Williston Park) 17:1578, 1583-5, 1589-90. 2003